Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001929248 | SCV002206808 | uncertain significance | Gastrointestinal stromal tumor | 2023-07-12 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 884 of the KIT protein (p.Lys884Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KIT-related conditions. ClinVar contains an entry for this variant (Variation ID: 1426138). |
Ambry Genetics | RCV004946895 | SCV005608884 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-12-04 | criteria provided, single submitter | clinical testing | The c.2651A>G (p.K884R) alteration is located in exon 19 (coding exon 19) of the KIT gene. This alteration results from a A to G substitution at nucleotide position 2651, causing the lysine (K) at amino acid position 884 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |